Avery Healthcare focuses on organic growth and acquisitions

Avery Healthcare has posted rising revenue and EBITDA as it continues to concentrate on growing operations organically and through acquisitions. The premium care provider posted revenue growth of 5.3% to £197.3m (2022: £187.3m), while cost of sales rose 11.5% to £106.4m (2022: £95.4m) and administrative expenses went down to £106.9m (£111.5m), its financial results for…

Membership Required

You must be a CM Subscriber to view this content.

Subscribe Now »

Already have an account?